Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Core Insights - Senti Biosciences, Inc. is participating in the Biotech Showcase 2026, highlighting its focus on next-generation cell and gene therapies using its proprietary Gene Circuit platform [1][3] - The panel presentation titled "Engineering the Future: Advances in Cell and Gene Therapies" will take place on January 13, 2026, at 8:00 AM PST [2] Company Overview - Senti Bio is a clinical-stage biotechnology company dedicated to developing innovative cell and gene therapies for patients with incurable diseases [4] - The company utilizes a synthetic biology platform to engineer Gene Circuits aimed at precisely targeting and killing cancer cells while sparing healthy cells [4] - Senti Bio's pipeline includes cell therapies designed to address challenging liquid and solid tumor indications, with preclinical evidence supporting the efficacy of Gene Circuits in both NK and T cells [4] Industry Context - The Biotech Showcase serves as a significant investor and networking conference for biotechnology and life sciences companies, providing a platform for presenting to investors and pharmaceutical executives [3] - This event is recognized for setting the tone for the biotechnology sector in the upcoming year, featuring multiple tracks, plenary sessions, and networking opportunities [3]